Found: 56
Select item for more details and to access through your institution.
AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09697-6
- By:
- Publication type:
- Article
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 3, p. 1043, doi. 10.1172/JCI78789
- By:
- Publication type:
- Article
Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. e77, doi. 10.1111/bjh.17029
- By:
- Publication type:
- Article
Distinctive and common features of moderate aplastic anaemia.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 967, doi. 10.1111/bjh.16460
- By:
- Publication type:
- Article
Current status of antibody therapy in ALL.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 4, p. 471, doi. 10.1111/bjh.13205
- By:
- Publication type:
- Article
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 233, doi. 10.1111/bjh.13035
- By:
- Publication type:
- Article
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13035
- By:
- Publication type:
- Article
SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 4, p. 504, doi. 10.1111/bjh.12778
- By:
- Publication type:
- Article
Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1and CBLMutations Are Present in Systemic Mastocytosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043090
- By:
- Publication type:
- Article
Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2011, v. 1, n. 1, p. 19
- By:
- Publication type:
- Article
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62345-9
- By:
- Publication type:
- Article
Recent advances and novel treatment paradigms in acute lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 5, p. 252, doi. 10.1177/2040620716652289
- By:
- Publication type:
- Article
Ribosomal S6 Kinase and AKT Phosphorylation as Pharmacodynamic Biomarkers in Patients With Myelodysplastic Syndrome Treated With RAD001.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 6, p. 473, doi. 10.3816/CLML.2010.n.082
- By:
- Publication type:
- Article
Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. 211, doi. 10.3816/CLML.2010.n.033
- By:
- Publication type:
- Article
Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 5, p. 425, doi. 10.1111/ejh.12862
- By:
- Publication type:
- Article
Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 4, p. 288, doi. 10.1111/j.1600-0609.2012.01825.x
- By:
- Publication type:
- Article
Survival and Predictors of Outcome in Patients With Acute Leukemia Admitted to the Intensive Care Unit.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 10, p. 2233, doi. 10.1002/cncr.23394
- By:
- Publication type:
- Article
Impact of Remission Induction Chemotherapy on Survival in Older Adults With Acute Myeloid Leukemia.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 8, p. 1752, doi. 10.1002/cncr.22976
- By:
- Publication type:
- Article
Barriers to the participation of African-American patients with cancer in clinical trials.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 6, p. 1499, doi. 10.1002/cncr.11213
- By:
- Publication type:
- Article
Time to First Subsequent Salvage Therapy in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin in the Phase III INO-VATE Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e836, doi. 10.1016/j.clml.2022.04.022
- By:
- Publication type:
- Article
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of Inotuzumab Ozogamicin in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Treated in the INO-VATE Trial: Outcomes by Salvage-Treatment Phase.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S191, doi. 10.1016/j.clml.2019.07.035
- By:
- Publication type:
- Article
More or Less? Impact of Dose Number on Outcomes of Patients with Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S190, doi. 10.1016/j.clml.2019.07.034
- By:
- Publication type:
- Article
TP53 Mutations in Myeloid Neoplasms and Clonal Hematopoiesis of Indeterminate Potential following Cytotoxic Therapy for Antecedent Malignancy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S264, doi. 10.1016/j.clml.2018.07.178
- By:
- Publication type:
- Article
Mutational Landscape of Therapy-Related Myeloid Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S263, doi. 10.1016/j.clml.2018.07.177
- By:
- Publication type:
- Article
Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S261, doi. 10.1016/j.clml.2018.07.172
- By:
- Publication type:
- Article
Perspectives and Future Directions for Acute Lymphoblastic Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00345-8
- By:
- Publication type:
- Article
Novel Therapies in Acute Lymphoblastic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 4, p. 289, doi. 10.1007/s11899-018-0457-7
- By:
- Publication type:
- Article
Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 408, doi. 10.1002/ajh.25394
- By:
- Publication type:
- Article
Treatment of young adults with Philadelphia‐negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper‐CVAD vs. pediatric‐inspired regimens.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1254, doi. 10.1002/ajh.25229
- By:
- Publication type:
- Article
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 660, doi. 10.1002/ajh.24736
- By:
- Publication type:
- Article
Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10).
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 8, p. 862, doi. 10.1002/ajh.23755
- By:
- Publication type:
- Article
Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 2, p. 168, doi. 10.1002/ajh.23605
- By:
- Publication type:
- Article
Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 10, p. 906, doi. 10.1002/ajh.23530
- By:
- Publication type:
- Article
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 10, p. 957, doi. 10.1002/ajh.23279
- By:
- Publication type:
- Article
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 11, p. 831, doi. 10.1002/ajh.21260
- By:
- Publication type:
- Article
Real-World Analysis of Oral Chemotherapy Dose Modifications During Maintenance Therapy for Young Adults With ALL.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 1, p. 18
- By:
- Publication type:
- Article
Blinatumomab: A Novel Agent to Treat Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2011, v. 9, n. 10, p. 776
- By:
- Publication type:
- Article
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATE.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 16, p. 3968, doi. 10.1002/cncr.26741
- By:
- Publication type:
- Article
A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 6, p. 1253, doi. 10.1002/cncr.25686
- By:
- Publication type:
- Article
Impact of Weekend Admissions on Quality of Care and Outcomes in Patients With Acute Myeloid Leukemia.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 15, p. 3614, doi. 10.1002/cncr.25086
- By:
- Publication type:
- Article
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 4, p. 504, doi. 10.1111/j.1365-2141.2011.08607.x
- By:
- Publication type:
- Article
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 5, p. 430, doi. 10.1111/j.1365-2141.2010.08387.x
- By:
- Publication type:
- Article
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 901, doi. 10.1093/oncolo/oyad114
- By:
- Publication type:
- Article
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 21, p. 3631, doi. 10.1002/cncr.35505
- By:
- Publication type:
- Article
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 905, doi. 10.1002/cncr.33321
- By:
- Publication type:
- Article